GE HealthCare Technologies (GEHC) Cash from Financing Activities (2022 - 2026)

GE HealthCare Technologies' Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $21.0 million for Q1 2026.

• Quarterly Cash from Financing Activities rose 107.34% year-over-year to $21.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $924.0 million (up 230.88% YoY) and the FY2025 annual result came in at $617.0 million, up 207.68% from the prior year.
• Cash from Financing Activities was $21.0 million for Q1 2026 at GE HealthCare Technologies, up from -$293.0 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $1.4 billion in Q2 2025 and bottomed at -$1.3 billion in Q4 2024.
• A 5-year average of -$72.6 million and a median of -$153.0 million in 2024 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities slumped 2332.43% — and 2024, when it jumped 3908.33%.
• GE HealthCare Technologies' Cash from Financing Activities stood at -$37.0 million in 2022, then slumped by 2332.43% to -$900.0 million in 2023, then plunged by 41.89% to -$1.3 billion in 2024, then jumped by 77.06% to -$293.0 million in 2025, then jumped by 107.17% to $21.0 million in 2026.
• Business Quant data shows GEHC's Cash from Financing Activities at $21.0 million in Q1 2026, -$293.0 million in Q4 2025, and -$165.0 million in Q3 2025.